Filter
171
Text search:
Moderna
Featured
Recommendations
18
New Publications
9
Language
Document type
Studies & Reports
38
Fact sheets
34
Guidelines
31
No document type
31
Manuals
10
Resource Platforms
7
Strategic & Response Plan
6
Training Material
4
Infographics
4
Online Courses
3
Brochures
1
Situation Updates
1
Videos
1
Countries / Regions
Germany
11
Argentina
10
Latin America and the Carribbean
9
Brazil
8
Global
8
Kenya
5
Ukraine
5
Paraguay
5
Colombia
4
Middle East and North Africa
4
China
3
Bolivia
3
Venezuela
3
Russia
3
Mozambique
2
Ecuador
2
Chile
2
Guinea-Bissau
1
Ghana
1
Haiti
1
Philippines
1
South Africa
1
Peru
1
El Salvador
1
Angola
1
Guatemala
1
East and Southern Africa
1
West and Central Africa
1
South–East Asia Region
1
Western and Central Europe
1
Africa
1
Eastern Europe
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
76
Clinical Guidelines
5
Public Health
3
Women & Child Health
3
Key Resources
3
Pharmacy & Technologies
2
Annual Report MEDBOX
1
Toolboxes
COVID-19
104
Mental Health
12
Refugee
6
TB
5
Conflict
3
Health Financing Toolbox
3
AMR
2
Social Ethics
2
Caregiver
2
Planetary Health
2
Pharmacy
2
Disability
1
Rapid Response
1
Zika
1
Specific Hazards
1
Global Health Education
1
NTDs
1
NCDs
1
These are standing orders for eligible nurses and healthcare professionals to administer the Moderna COVID-19 vaccine to persons 18 years of age and older
nterim guidance, first issued 25 January 2021, updated 15 June 2021, updated 19 November 2021, updated 23 February 2022, updated 18 August 2022
orientations provisoires, première publication le 25 janvier 2021, mise à jour le 15 juin 2021, mise à jour le 19 novembre 2021
Vaccinator's Manual. MODERNA Vaccine
El siguiente manual se continuará actualizando, de ser necesario, a medida que se disponga de nueva información.
FEY ENFOMASYON POU MOUN K’AP RESEVWA AVEK MOUN K’AP BAY SWEN OTORIZASYON POU ITILIZASYON IJANS (EUA) POU VAKSIN MODERNA COVID-19 POU ANPECHE CORONAVIRUSDISEASE 2019
(COVID-19) NAN PERSONN 18 ANE AK PI GRAN
Early data from US biotech Moderna has revealed that its Covid-19 vaccine candidate is 94.5 per cent effective, raising hopes that a range of immunisations will be available to help end the pandemic.
The interim analysis of the vaccine, currentl
...
Comirnaty® 10 μg und 30 μg von BioNTech / Pfizer und Spikevax® von Moderna
Stand 21. Dezember 2021
Comirnaty® 10 μg und 30 μg von BioNTech / Pfizer und Spikevax® von Moderna
(Comirnaty® 10 мкг або 30 мкг виробництва BioNTech/Pfizer та Spikevax® виробництва Moderna);
Anamnese zur Schutzimpfung gegen COVID-19 (Corona Virus Disease 2019) (Grundimmunisierung und Auffrischimpfungen)
–
...
– (Comirnaty® 10 мкг або 30 мкг виробництва BioNTech/Pfizer та
AUFKLÄRUNGSMERKBLATT
Zur Schutzimpfung gegen COVID-19 (Corona Virus Disease 2019) (Grundimmunisierung und Auffrischimpfungen)
– mit mRNA-Impfstoffen –
(Comirnaty® 10 μg bzw. 30 μg von BioNTech/Pfizer
...
Existen notificaciones de eventos relacionados con la vacuna (ESAVI) de
miocarditis/pericarditis en adolescentes tras la administración de vacunas ARNm(Pfizer y Moderna) especialmente tras la segunda dosis. Al momento no seencuentra asociación en
...
La dosis de refuerzo está indicada una vez transcurridos los 4 meses (120 días) de la última dosis del esquema inicial y será con vacuna de plataforma ARNm: Pfizer-BioNTech pediátrica a partir de los 5 años o Moderna para uso pediátrico a par
...
En Paraguay, la vacunación contra COVID-19 inició el 22 de febrero de 2021. Se han autorizado un total de siete vacunas: Bharat-Covaxin, Moderna, Pfizer-BioNTech, AstraZeneca, Sinopharm, Sputnik V- Gamaleya y CoronaVac-Sinovac. Los grupos priorita
...
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical industry was restricting access to Covid-19 vaccines. This report updates that assessment
...
